Synapse - Elizabeth Hoover

Results (30)

Urinary excretion of epinephrine and dopamine correlates with efficiency of G-CSF mobilized stem cells in patients with AL amyloidosis

Meeting Abstract

Landau, H. J.; Bello, C.; Hoover, E.; Riedel, E.; Frenette, P.; Comenzo, R. L.
Biology of Blood and Marrow Transplantation (2012)

Fulltext@MSK | Save

Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease

Journal Article

Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
Leukemia and Lymphoma (2012)

Fulltext@MSK | Save

Urinary excretion of epinephrine and dopamine correlates with efficiency of G-CSF mobilized stem cells in patients with AL amyloidosis

Meeting Abstract

Landau, H.; Hassoun, H.; Hoffman, J. E.; Bello, C.; Hoover, E.; Riedel, E.; Frenette, P. S.; Comenzo, R. L.
Blood (2011)

Fulltext@MSK | Save

Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis

Journal Article

Landau, H.; Hassoun, H.; Bello, C.; Hoover, E.; Riedel, E. R.; Nimer, S. D.; Comenzo, R. L.
Amyloid (2011)

Fulltext@MSK | Save

Maintained hematologic and organ responses at two years following stem cell transplant in systemic light-chain amyloidosis (AL) using short-course bortezomib and dexamethasone consolidation therapy

Meeting Abstract

Landau, H.; Hassoun, H.; Rosenzweig, M. A.; Bello, C.; Hoover, E.; Riedel, E.; Lesokhin, A.; Lendvai, N.; Cohen, A.; Nimer, S.; more...
Blood (2010)

Fulltext@MSK | Save

Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis

Meeting Abstract

Landau, H.; Hassoun, H.; Bello, C.; Hoover, E.; Jia, X.; Riedel, E. R.; Nimer, S. D.; Comenzo, R. L.
Amyloid (2010)

Fulltext@MSK | Save

FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone

Meeting Abstract

Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study

Meeting Abstract

Landau, H.; Hassoun, H.; Cohen, A. D.; Lesokhin, A.; Bello, C.; Hoover, E.; Riedel, E. R.; Ciminiello, J.; McCullagh, E.; Nimer, S. D.; more...
Blood (2009)

Fulltext@MSK | Save

Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response

Meeting Abstract

Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
Blood (2008)

Fulltext@MSK | Save

Early adjuvant treatment after risk-adapted autologous stem cell transplant for systemic light-chain amyloidosis: Increased hospitalizations and impaired immune recovery but improved responses and overall survival

Meeting Abstract

Hoffman, J. E.; Hassoun, H.; Landau, H.; Hoover, E.; Cohen, A.; Nimer, S.; Comenzo, R.
Blood (2008)

Fulltext@MSK | Save